Trial Profile
A Randomized, Open-label, Multiple Doses, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction and Safety of Telmisartan Between Free Combination of Telmisartan and S-amlodipine and Telmisartan Monotherapy in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2011
Price :
$35
*
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Telmisartan
- Indications Cardiovascular disorders; Essential hypertension; Hypertension
- Focus Pharmacokinetics
- 06 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 May 2011 New trial record